Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Elmer

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Infection Control and Hospital Epidemiology|February 2, 1999
Recurrent Clostridium difficile disease: epidemiology and clinical characteristicsL V McFarland, C M Surawicz, M Rubin, et al.
Gastroenterology|April 1, 1989
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective studyC M Surawicz, G W Elmer, P Speelman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1997
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trialR Fekety, L V McFarland, C M Surawicz, et al.
Lancet (London, England)|October 7, 1995
Ciprofloxacin-associated Clostridium difficile diseaseL V McFarland, J E Bauwens, S A Melcher, et al.
The American Journal of Gastroenterology|March 1, 1995
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placeboL V McFarland, C M Surawicz, R N Greenberg, et al.
JAMA|June 22, 1994
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile diseaseL V McFarland, C M Surawicz, R N Greenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardiiC M Surawicz, L V McFarland, R N Greenberg, et al.
Clinical Therapeutics|February 25, 2000
Antibiotics and Clostridium difficile diarrhea in the ambulatory care settingD G Levy, A Stergachis, L V McFarland, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Infection Control and Hospital Epidemiology|February 2, 1999
Recurrent Clostridium difficile disease: epidemiology and clinical characteristicsL V McFarland, C M Surawicz, M Rubin, et al.
Gastroenterology|April 1, 1989
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective studyC M Surawicz, G W Elmer, P Speelman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1997
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trialR Fekety, L V McFarland, C M Surawicz, et al.
Lancet (London, England)|October 7, 1995
Ciprofloxacin-associated Clostridium difficile diseaseL V McFarland, J E Bauwens, S A Melcher, et al.
The American Journal of Gastroenterology|March 1, 1995
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placeboL V McFarland, C M Surawicz, R N Greenberg, et al.
JAMA|June 22, 1994
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile diseaseL V McFarland, C M Surawicz, R N Greenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardiiC M Surawicz, L V McFarland, R N Greenberg, et al.
Clinical Therapeutics|February 25, 2000
Antibiotics and Clostridium difficile diarrhea in the ambulatory care settingD G Levy, A Stergachis, L V McFarland, et al.
Pageof 4